Role of RHOA-GTPASES activator, GEF-H1, in thyroid cancer
; Carballido, Jessica Andrea
; Alonso, Exequiel Gonzalo
; Gandini, Norberto Ariel
; Mascaró, Marilina
; Pichel, Pamela ; Recio, Sergio ; Curino, Alejandro Carlos
; Facchinetti, Maria Marta
; Colo, Georgina Pamela 
Fecha
2020
Editorial
Fundación Revista Medicina
Revista
Título del libro
Nombre del evento
LXV Reunión Anual De La Sociedad Argentina De Investigación Clínica; LXIII Reunión Anual De La Sociedad Argentina De Inmunología y Reunión Anual De La Sociedad Argentina De Fisiología
Fecha del evento
2020-11-10
Institución organizadora
Sociedad Argentina de Investigación Clínica
Sociedad Argentina de Inmunología
Sociedad Argentina de Fisiología
Sociedad Argentina de Inmunología
Sociedad Argentina de Fisiología
ISSN
0025-7680
eISSN
1669-9106
ISBN
Idioma
Inglés
Tipo del evento
Reunión
Clasificación temática
Palabras clave
Resumen
GEF-H1 is a Rho-GTPases activator whose overexpression has been shown to be associated with tumor development. However, its role in thyroid cancer (TC) progression has not yet been stud- ied. TC has been dramatically rising worldwide in recent decades and represents the most prevalent endocrine malignancy. For this reason, we have begun analyzing GEF-H1 expression in human thyroid biopsies. We observed higher cytoplasmic protein concen- tration when comparing by immunohistochemistry tumor tissue (TT) with non-malignant tissue (NMT) (n=52; p=0.0003). Similar results were obtained by Western blot in thyroid biopsies and cancer cell lines. Furthermore, clinical-histopathological data showed signifi- cant GEF-H1 overexpression in TT than NMT (p=7E-07), which cor- relates with a less patient survival (p=0.0088). mRNA data analysis from biopsies (Human Protein Atlas and Oncomine platforms) also showed a significant GEF-H1 overexpression in TT compared with NMT. Analyzing Gene Expression Omnibus microarray data with R language, we observed that GEF-H1 is between 2-17% of the most expressed genes in different TC histotypes. We also determined that GEF-H1 expression is significantly higher in papillary and anaplas- tic carcinomas than NMT (p<0.05) and its expression increased in papillary carcinomas with lymph node invasion and/or metastasis (p<0.001). Moreover, we looked for those genes whose mRNA ex- pression correlates with GEF-H1 and we evaluated their function through gene ontology analysis (DAVID and STRING platforms) and their participation in signaling pathways (KEGG and Reactome). Genes associated with migration, mechanical signaling, cytoskele- ton remodeling and focal adhesions positive correlated with GEF-H1 expression in TC (p<0.001). The results suggest that GEF-H1 might be a potential tumor biomarker and/or therapeutic target in TC, since it would be involved in the pro-tumorigenic signaling by coordinating changes in cell morphology, proliferation, migration and invasion
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
